F-STAR THERAPEUTICS INC (FSTX)
US30315R1077 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to FSTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 0.28% above the current price.
FSTX was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about FSTX.
In the previous month the buy percentage consensus was at a similar level.
FSTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-24 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-11 | SVB Leerink | Maintains | Outperform |
| 2021-08-17 | SVB Leerink | Maintains | Outperform |
| 2021-07-08 | SVB Leerink | Initiate | Outperform |
| 2021-06-09 | B. Riley Securities | Initiate | Buy |
| 2021-05-18 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-16 | Oppenheimer | Initiate | Outperform |
| 2021-04-08 | William Blair | Initiate | Outperform |
| 2021-03-24 | Laidlaw & Co. | Initiate | Buy |
| 2021-03-01 | HC Wainwright & Co. | Initiate | Buy |